FDA Approves Wegovy to Help Prevent Heart Attack, Stroke

FRIDAY, March 8, 2024-- Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death.“Wegovy is now the...